UBS Group Has Lowered Expectations for CVS Health (NYSE:CVS) Stock Price

CVS Health (NYSE:CVS) had its price objective dropped by equities researchers at UBS Group from $118.00 to $107.00 in a research note issued to investors on Thursday, Benzinga reports. The brokerage currently has a “buy” rating on the pharmacy operator’s stock. UBS Group‘s price objective points to a potential upside of 27.75% from the stock’s current price.

Several other equities analysts have also issued reports on CVS. Robert W. Baird set a $107.00 price target on shares of CVS Health in a report on Thursday, August 6th. Raymond James Financial reiterated an “outperform” rating and set a $120.00 price objective on shares of CVS Health in a report on Wednesday. Weiss Ratings cut CVS Health from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Friday, October 9th. Sanford C. Bernstein restated an “outperform” rating and set a $112.00 target price on shares of CVS Health in a research note on Wednesday, September 9th. Finally, Royal Bank Of Canada upped their target price on CVS Health from $107.00 to $113.00 and gave the company an “outperform” rating in a research report on Thursday, July 9th. Twenty-two equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $108.25.

CVS Health Stock Up 3.0%

CVS Health stock traded up $2.43 during trading hours on Thursday, reaching $83.76. The stock had a trading volume of 16,092,787 shares, compared to its average volume of 8,249,097. The company has a market cap of $107.12 billion, a price-to-earnings ratio of 9.75, a PEG ratio of 0.82 and a beta of 0.58. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.87 and a quick ratio of 0.66. The business’s 50 day moving average price is $90.37 and its 200-day moving average price is $88.89. CVS Health has a 52 week low of $69.51 and a 52 week high of $110.68.

CVS Health (NYSE:CVS) last released its quarterly earnings results on Wednesday, November 4th. The pharmacy operator reported $2.09 earnings per share for the quarter, beating analysts’ consensus estimates of $1.65 by $0.44. CVS Health had a net margin of 1.18% and a return on equity of 13.12%. The business had revenue of $108.40 billion for the quarter, compared to analysts’ expectations of $104.72 billion. During the same period last year, the business earned $1.60 EPS. The company’s revenue was up 5.4% compared to the same quarter last year. Sell-side analysts anticipate that CVS Health will post 8.26 EPS for the current year.

Insider Buying and Selling at CVS Health

In other news, EVP Prem Shah bought 23,855 shares of the business’s stock in a transaction that occurred on Friday, November 6th. The shares were purchased at an average cost of $83.89 per share, with a total value of $2,001,195.95. Following the transaction, the executive vice president directly owned 88,516 shares in the company, valued at approximately $7,425,607.24. The trade was a 36.89% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. 0.85% of the stock is owned by company insiders.

Institutional Trading of CVS Health

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the company. BlackRock Inc. purchased a new position in shares of CVS Health in the second quarter worth about $12,747,462,000. State Street Corp increased its holdings in CVS Health by 26.3% in the 2nd quarter. State Street Corp now owns 74,927,064 shares of the pharmacy operator’s stock worth $7,751,205,000 after buying an additional 15,604,883 shares during the period. Wellington Management Group LLP raised its position in CVS Health by 49.8% during the 2nd quarter. Wellington Management Group LLP now owns 33,801,113 shares of the pharmacy operator’s stock worth $3,496,725,000 after buying an additional 11,233,381 shares during the last quarter. Bank of America Corp DE boosted its holdings in shares of CVS Health by 148.0% in the 2nd quarter. Bank of America Corp DE now owns 23,188,670 shares of the pharmacy operator’s stock valued at $2,398,868,000 after acquiring an additional 13,836,701 shares during the last quarter. Finally, Pzena Investment Management LLC acquired a new stake in shares of CVS Health in the second quarter worth $1,217,558,000. Institutional investors and hedge funds own 80.66% of the company’s stock.

Key Headlines Impacting CVS Health

Here are the key news stories impacting CVS Health this week:

• Positive Sentiment: Executive Vice President Prem Shah bought 23,855 shares for about $2 million, increasing his direct stake by 36.9%. The sizable purchase may signal confidence in CVS’s prospects. SEC filing
• Positive Sentiment: CVS beat third-quarter earnings and revenue estimates and raised its 2026 outlook, with Aetna’s recovery among the factors supporting the improved outlook. Q3 earnings call coverage
• Neutral Sentiment: UBS lowered its price target to $107 but maintained a Buy rating, indicating continued optimism while reflecting a more cautious valuation. UBS rating
• Negative Sentiment: The planned separation of the retail pharmacy business from the insurance and pharmacy-benefit operations by 2028 has raised questions about execution, costs, and the value of the two businesses. The announcement overshadowed the earnings beat and was followed by a sharp selloff. Breakup and stock reaction
• Negative Sentiment: Additional concerns include weaker Medicare ratings and AM Best placing ratings for Aetna subsidiaries under review, creating uncertainty around the insurance business. Medicare ratings coverage

CVS Health Company Profile

CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division.

The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.

Founded in 1963 as Consumer Value Stores in Lowell, Massachusetts, the company expanded from a retail pharmacy business into a broad health care organization and adopted the CVS Health name in 2014.